Related Experiment Video
Updated: Oct 15, 2025

09:17
Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
Published on: September 13, 2022
2.4K
In-depth proteomic profiling captures subtype-specific features of craniopharyngiomas
Jung Hee Kim1,2, Hyeyoon Kim3,4, Kisoon Dan3
1Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Scientific Reports
|October 28, 2021
Summary
This study reveals distinct proteomic differences between adamantinomatous craniopharyngioma (ACP) and papillary craniopharyngioma (PCP) subtypes. These findings offer insights into craniopharyngioma pathogenesis and potential subtype-specific treatments.
Area of Science:
- Oncology
- Proteomics
- Molecular Biology
Background:
- Craniopharyngiomas are rare tumors originating from pituitary embryonic tissue.
- They present as two main subtypes: adamantinomatous (ACP) and papillary (PCP), with distinct characteristics.
- While genomic and transcriptomic data exist, proteomic profiles remain largely unexplored.
Purpose of the Study:
- To investigate and compare the proteomic profiles of ACP and PCP subtypes.
- To identify subtype-specific protein expression patterns.
- To uncover potential proteomic biomarkers for craniopharyngioma classification.
Main Methods:
- System-level proteomic analysis using mass spectrometry-based quantitative proteomics.
- Integration of statistical and bioinformatics analyses.
- Network analysis to identify key proteins (hub proteins).
Main Results:
- Significant proteomic differences were identified between ACP and PCP.
- Differentially expressed proteins are involved in mitochondrial organization, fatty acid metabolism, inflammation, cell cycle, RNA splicing, cell migration, and neuron development.
- Hub proteins correlated with specific craniopharyngioma phenotypes were identified.
Conclusions:
- This proteomic study enhances the understanding of craniopharyngioma subtype pathogenesis.
- Identified proteins and pathways provide novel insights for developing targeted therapies.
- Proteomic profiling is crucial for distinguishing craniopharyngioma subtypes and guiding treatment strategies.

